3 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Visus Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia BRIMOCHOL™ PF, Carbachol PF, Brimonidine tartrate - Presbyopia | Phase 3 | Completed | Visus Therapeutics | 182 | 2022-03-30 | 2024-10-15 |
| Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia BRIMOCHOL™ PF, Carbachol PF, Vehicle - Presbyopia | Phase 3 | Completed | Visus Therapeutics | 629 | 2022-03-15 | 2025-08-06 |
| Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia BRIMOCHOL™, BRIMOCHOL™ F, Carbachol - Presbyopia | Phase 2 | Completed | Visus Therapeutics | 18 | 2021-03-24 | 2026-03-27 |
Presbyopia (3)
Brimonidine Tartrate (3) · Carbachol (3)
United States (3)